These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 19544375)

  • 1. Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience.
    Pereira-Martins DA; Weinhäuser I; Coelho-Silva JL; Ammatuna E; Huls G; Schuringa JJ; Rego EM; Lucena-Araujo AR
    Lancet Haematol; 2024 Feb; 11(2):e98-e99. PubMed ID: 38302230
    [No Abstract]   [Full Text] [Related]  

  • 2. Global characteristics of childhood acute promyelocytic leukemia.
    Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
    Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes.
    Li EQ; Xu L; Zhang ZQ; Xiao Y; Guo HX; Luo XQ; Hu Q; Lai DB; Tu LM; Jin RM
    Exp Ther Med; 2012 Jul; 4(1):93-98. PubMed ID: 23060929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of tretinoin in acute promyelocytic leukaemia.
    Schmitt K; Schwarz R; Tulzer G; Krieger O; Zoubek A; Gadner H
    Lancet; 1994 Feb; 343(8893):361. PubMed ID: 7905174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Retinoid therapy of acute promyelocytic leukemia].
    Ellegaard J
    Ugeskr Laeger; 1994 Mar; 156(11):1660. PubMed ID: 8009665
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment.
    Matsumoto K; Tamaki H; Yamagami T; Sasaki N; Hara S; Soma T
    Leuk Res; 2008 Mar; 32(3):512-4. PubMed ID: 17588659
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Sep; 53(3):325-8. PubMed ID: 19422024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries.
    Rizzari C; Biondi A
    Pediatr Blood Cancer; 2009 Sep; 53(3):303-5. PubMed ID: 19544375
    [No Abstract]   [Full Text] [Related]  

  • 9. Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
    Adès L; Fenaux P
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):678-82. PubMed ID: 17099625
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pathogenesis and treatment of the hemostatic disorder in acute promyelocytic leukemia].
    Velasco F; López-Pedrera R; Páramo JA
    Med Clin (Barc); 1996 Jun; 107(2):59-61. PubMed ID: 8753897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostics and therapy of acute myeloid leukemia].
    Bornhäuser M; Ehninger G
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1935-41. PubMed ID: 19760554
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.